Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin

References

• Vinik A Ullal J Parson HK Casellini CM Diabetic neuropathies: clinical manifestations and current treatment options Nat Clin Pract Endocrinol Metab 2006 2 269 281 16932298
   PubMedGoogle Scholar
• Sadosky A McDermott AM Brandenburg NA Strauss M A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions Pain Pract 2008 8 45 56 18211592
   PubMedGoogle Scholar
• Tesfaye S Boulton AJ Dyck PJ Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 2010 33 2285 2293 20876709
   PubMed Web of Science ®Google Scholar
• Ziegler D Painful diabetic neuropathy: treatment and future aspects Diabetes Metab Res Rev 2008 24 Suppl 1 S52 S57 18395890
   PubMed Web of Science ®Google Scholar
• Boulton AJ Malik RA Arezzo JC Sosenko JM Diabetic somatic neuropathies Diabetes Care 2004 27 1458 1486 15161806
   PubMed Web of Science ®Google Scholar
• Vinik AI Ziegler D Diabetic cardiovascular autonomic neuropathy Circulation 2007 115 387 397 17242296
   PubMed Web of Science ®Google Scholar
• Vinik AI Maser RE Ziegler D Neuropathy: the crystal ball for cardiovascular disease? Diabetes Care 2010 33 1688 1690 20587730
   PubMed Web of Science ®Google Scholar
• Vinik A Maser R Ziegler D Autonomic imbalance: prophet of doom or scope for hope? Diabet Med 2011 28 643 651 21569084
   PubMed Web of Science ®Google Scholar
• Mantyselka P Ahonen R Kumpusalo E Takala J Variability in prescribing for musculoskeletal pain in Finnish primary health care Pharm World Sci 2001 23 232 236 11826513
   PubMedGoogle Scholar
• Treede RD Jensen TS Campbell JN Neuropathic pain: redefinition and a grading system for clinical and research purposes Neurology 2008 70 1630 1635 18003941
   PubMed Web of Science ®Google Scholar
• Jensen MP Chodroff MJ Dworkin RH The impact of neuropathic pain on health-related quality of life: review and implications Neurology 2007 68 1178 1182 17420400
   PubMed Web of Science ®Google Scholar
• Bouhassira D Lanteri-Minet M Attal N Laurent B Touboul C Prevalence of chronic pain with neuropathic characteristics in the general population Pain 2008 136 380 387 17888574
   PubMed Web of Science ®Google Scholar
• Vinik EJ Hayes RP Oglesby A The development and validation of the Norfolk QOL-DN, a new measure of patients’ perception of the effects of diabetes and diabetic neuropathy Diabetes Technol Ther 2005 7 497 508 15929681
   PubMedGoogle Scholar
• Vinik E Paulson J Ford-Molvik S Vinik A German-translated Norfolk quality of life (QOL-DN) identifies the same factors as the English version of the tool and discriminates different levels of neuropathy severity J Diabetes Sci Technol 2008 2 1075 1086 19885296
   PubMedGoogle Scholar
• Bril V England J Franklin GM Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology 2011 76 1758 1765 21482920
   PubMed Web of Science ®Google Scholar
• Castro MM Daltro C Sleep patterns and symptoms of anxiety and depression in patients with chronic pain Arq Neuropsiquiatr 2009 67 25 28 19330205
   PubMed Web of Science ®Google Scholar
• Gore M Brandenburg NA Dukes E Hoffman DL Tai KS Stacey B Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep J Pain Symptom Manage 2005 30 374 385 16256902
   PubMed Web of Science ®Google Scholar
• Boulanger L Zhao Y Foster TS Fraser K Bledsoe SL Russell MW Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain Curr Med Res Opin 2009 25 1763 1773 19505204
   PubMed Web of Science ®Google Scholar
• Gupta A Silman J Ray D The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study Rheumatology (Oxford) 2007 46 666 671 17085772
   PubMed Web of Science ®Google Scholar
• Vinik A Zlateva G Cheung R Murphy K Emir B Whalen E Understanding the impact of pain response on changes in function, quality of life, and sleep interference in patients with painful diabetic peripheral neuropathy and post-herpetic neuralgia treated with pregabalin J Pain 2010 11 S17
   Google Scholar
• O’Connor AB Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy Pharmacoeconomics 2009 27 95 112 19254044
   PubMed Web of Science ®Google Scholar
• Van Acker K Bouhassira D De Bacquer D Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics Diabetes Metab 2009 35 3 206 213 19297223
   PubMed Web of Science ®Google Scholar
• Daousi C MacFarlane IA Woodward A Nurmikko TJ Bundred PE Benbow SJ Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes Diabet Med 2004 21 976 982 15317601
   PubMed Web of Science ®Google Scholar
• Krein SL Heisler M Piette JD Makki F Kerr EA The effect of chronic pain on diabetes patients’ self-management Diabetes Care 2005 28 65 70 15616235
   PubMed Web of Science ®Google Scholar
• Zelman DC Brandenburg NA Gore M Sleep impairment in patients with painful diabetic peripheral neuropathy Clin J Pain 2006 22 681 685 16988563
   PubMed Web of Science ®Google Scholar
• Torrance N Smith BH Bennett MI Lee AJ The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey J Pain 2006 7 281 289 16618472
   PubMed Web of Science ®Google Scholar
• Dieleman JP Kerklaan J Huygen FJ Bouma PA Sturkenboom MC Incidence rates and treatment of neuropathic pain conditions in the general population Pain 2008 137 681 688 18439759
   PubMed Web of Science ®Google Scholar
• Cornblath DR Vinik A Feldman E Freeman R Boulton AJ Surgical decompression for diabetic sensorimotor polyneuropathy Diabetes Care 2007 30 421 422 17259523
   PubMed Web of Science ®Google Scholar
• Smith AG Russell J Feldman EL Lifestyle intervention for pre- diabetic neuropathy Diabetes Care 2006 29 1294 1299 16732011
   PubMed Web of Science ®Google Scholar
• Ziegler D Rathmann W Meisinger C Dickhaus T Mielck A Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry Eur J Pain 2009 13 582 587 18782673
   PubMed Web of Science ®Google Scholar
• Ziegler D Rathmann W Dickhaus T Meisinger C Mielck A Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3 Pain Med 2009 10 393 400 19207236
   PubMed Web of Science ®Google Scholar
• Pittenger G Mehrabyan A Simmons K Small fiber neuropathy is associated with the metabolic syndrome Metab Syndr Relat Disord 2005 3 113 121 18370718
   PubMed Web of Science ®Google Scholar
• Tesfaye S Chaturvedi N Eaton SE Vascular risk factors and diabetic neuropathy N Engl J Med 2005 352 341 350 15673800
   PubMed Web of Science ®Google Scholar
• Abbott CA Malik RA Van Ross ER Kulkarni J Boulton AJ Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK Diabetes Care 2011 34 2220 2224 21852677
   PubMed Web of Science ®Google Scholar
• Boulton AJ Armstrong WD Scarpello JH Ward JD The natural history of painful diabetic neuropathy – a 4-year study Postgrad Med J 1983 59 556 559 6634554
   PubMed Web of Science ®Google Scholar
• Galer BS Gianas A Jensen MP Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life Diabetes Res Clin Pract 2000 47 123 128 10670912
   PubMed Web of Science ®Google Scholar
• Young RJ Ewing DJ Clarke BF Chronic and remitting painful diabetic polyneuropathy. Correlations with clinical features and subsequent changes in neurophysiology Diabetes Care 1988 11 34 40 3338378
   PubMed Web of Science ®Google Scholar
• Benbow SJ Chan AW Bowsher D MacFarlane IA Williams G A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy Diabet Med 1994 11 17 21 8181246
   PubMed Web of Science ®Google Scholar
• Vinik AI Strotmeyer ES Nakave AA Patel CV Diabetic neuropathy in older adults Clin Geriatr Med 2008 24 407 435 v 18672180
   PubMed Web of Science ®Google Scholar
• De Micheli A Italian standards for diabetes mellitus 2007: executive summary: Diabete Italia, AMD Associazione Medici Diabetologi, SID Società Italiana di Diabetologia Acta Diabetol 2008 45 107 127
   Google Scholar
• Bennett MI Attal N Backonja MM Using screening tools to identify neuropathic pain Pain 2007 127 199 203 17182186
   PubMed Web of Science ®Google Scholar
• Bastyr E Zhang D Bril V MBBQ Study Group Neuropathy total symptom score-6 questionnaire (NTSS-6) is a valid instrument for assessing the positive symptoms of diabetic peripheral neuropathy (DPN) Diabetes 2002 51 A199
   Web of Science ®Google Scholar
• Scholz J Mannion RJ Hord DE A novel tool for the assessment of pain: validation in low back pain PLoS Med 2009 6 e1000047 19360087
   PubMed Web of Science ®Google Scholar
• Spallone V Painful Diabetic Neuropathy: Approach to diagnosis and treatment of an emergent problem Me Dia 2009 9 1 14
   Google Scholar
• Young RJ Structural functional interactions in the natural history of diabetic polyneuropathy: a key to the understanding of neuropathic pain? Diabet Med 1993 10 Suppl 2 89S 90S 8334853
   PubMed Web of Science ®Google Scholar
• Feldman EL Stevens MJ Thomas PK Brown MB Canal N Greene DA A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy Diabetes Care 1994 17 1281 1289 7821168
   PubMed Web of Science ®Google Scholar
• Loeser JD Treede RD The Kyoto protocol of IASP Basic Pain Terminology Pain 2008 137 473 477 18583048
   PubMed Web of Science ®Google Scholar
• Bouhassira D Attal N Fermanian J Development and validation of the Neuropathic Pain Symptom Inventory Pain 2004 108 248 257 15030944
   PubMed Web of Science ®Google Scholar
• Bennett MI Smith BH Torrance N Potter J The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research J Pain 2005 6 149 158 15772908
   PubMed Web of Science ®Google Scholar
• Krause S Backonja M Development of a neuropathic pain questionnaire Clin J Pain 2003 19 306 314 12966256
   PubMed Web of Science ®Google Scholar
• Bouhassira D Attal N Alchaar H Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) Pain 2005 114 29 36 15733628
   PubMed Web of Science ®Google Scholar
• Freyhagen R Baron R Gockel U Pain Detect: a new screening questionnaire to detect neuropathic components in patients with back pain Curr Med Res Opin 2006 22 1911 1920 17022849
   PubMed Web of Science ®Google Scholar
• Portenoy R Development and testing of a neuropathic pain screening questionnaire: ID Pain Curr Med Res Opin 2006 22 1555 1565 16870080
   PubMed Web of Science ®Google Scholar
• Dworkin RH Turk DC Revicki DA Development and initial validation of an expanded and revised version of the Short-Form McGill Pain Questionnaire (SF-MPQ-2) Pain 2009 144 35 42 19356853
   PubMed Web of Science ®Google Scholar
• Daut RL Cleeland CS Flanery RC Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases Pain 1983 17 197 210 6646795
   PubMed Web of Science ®Google Scholar
• Dworkin RH Turk DC Wyrwich KW Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations J Pain 2008 9 105 121 18055266
   PubMed Web of Science ®Google Scholar
• Cruccu G Truini A Tools for assessing neuropathic pain PLoS Med 2009 6 e1000045 19360134
   PubMed Web of Science ®Google Scholar
• Lauria G Hsieh S Johansson O European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society Eur J Neurol 2010 17 903 912 20642627
   PubMed Web of Science ®Google Scholar
• Stephenson DT Arneric SP Neuroimaging of pain: advances and future prospects J Pain 2008 9 567 579 18455479
   PubMed Web of Science ®Google Scholar
• Chao CC Hsieh SC Tseng MT Chang YC Hsieh ST Patterns of contact heat evoked potentials (CHEP) in neuropathy with skin denervation: correlation of CHEP amplitude with intraepidermal nerve fiber density Clin Neurophysiol 2008 119 653 661 18164654
   PubMed Web of Science ®Google Scholar
• Atherton DD Facer P Roberts KM Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts BMC Neurol 2007 7 21 17683543
   PubMed Web of Science ®Google Scholar
• Casanova-Molla J Grau-Junyent JM Morales M Valls-Sole J On the relationship between nociceptive evoked potentials and intraepidermal nerve fiber density in painful sensory polyneuropathies Pain 2011 152 410 418 21185650
   PubMed Web of Science ®Google Scholar
• Chao CC Tseng MT Lin YJ Pathophysiology of neuropathic pain in type 2 diabetes: skin denervation and contact heat-evoked potentials Diabetes Care 2010 33 2654 2659 20841612
   PubMed Web of Science ®Google Scholar
• Wong MC Chung JW Feasibility of contact heat evoked potentials for detection of diabetic neuropathy Muscle Nerve 2011 44 902 906 22102460
   PubMed Web of Science ®Google Scholar
• Casellini CM Vinik AI Clinical manifestations and current treatment options for diabetic neuropathies Endocr Pract 2007 13 550 566 17872358
   PubMedGoogle Scholar
• Finnerup NB Otto M McQuay HJ Jensen TS Sindrup SH Algorithm for neuropathic pain treatment: an evidence based proposal Pain 2005 118 289 305 16213659
   PubMed Web of Science ®Google Scholar
• Finnerup NB Sindrup SH Jensen TS The evidence for pharmacological treatment of neuropathic pain Pain 2010 150 573 581 20705215
   PubMed Web of Science ®Google Scholar
• Dworkin RH O’Connor AB Backonja M Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 2007 132 237 251 17920770
   PubMed Web of Science ®Google Scholar
• Dworkin RH O’Connor AB Audette J Recommendations for the pharmacological management of neuropathic pain: an overview and literature update Mayo Clin Proc 2010 85 S3 S14 20194146
   PubMed Web of Science ®Google Scholar
• Vinik A The approach to the management of the patient with neuropathic pain J Clin Endocrinol Metab 2010 95 4802 4811 21051576
   PubMed Web of Science ®Google Scholar
• Edelsberg J Oster G Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain? Eur J Pain 2009 13 11 16 18456524
   PubMed Web of Science ®Google Scholar
• Tesfaye S Vileikyte L Rayman G Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management Diabetes Metab Res Rev 2011 27 629 638
   PubMed Web of Science ®Google Scholar
• Said G Bigo A Ameri A Uncommon early-onset neuropathy in diabetic patients J Neurol 1998 245 61 68 9507409
   PubMed Web of Science ®Google Scholar
• Dogrul A Uzbay IT Topical clonidine antinociception Pain 2004 111 385 391 15363883
   PubMed Web of Science ®Google Scholar
• Ziegler D Nowak H Kempler P Vargha P Low PA Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis Diabet Med 2004 21 114 121 14984445
   PubMed Web of Science ®Google Scholar
• Ziegler D Ametov A Barinov A Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial Diabetes Care 2006 29 2365 2370 17065669
   PubMed Web of Science ®Google Scholar
• Ziegler D Low PA Boulton AJM Antioxidant treatment with alphalipoic acid in diabetic polyneuropathy: a 4-year randomized double-blind trial (NATHAN 1) Diabetologia 2011 50 S63
   Google Scholar
• Ziegler D Low PA Litchy WJ Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial Diabetes Care 2011 34 2054 2060 21775755
   PubMed Web of Science ®Google Scholar
• Ziegler D Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review Treat Endocrinol 2004 3 173 189 16026113
   PubMedGoogle Scholar
• Rains C Bryson HM Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis Drugs Aging 1995 7 317 328 8535059
   PubMed Web of Science ®Google Scholar
• Derry S Lloyd R Moore RA McQuay HJ Topical capsaicin for chronic neuropathic pain in adults Cochrane Database Syst Rev 2009 4 CD007393 19821411
   PubMed Web of Science ®Google Scholar
• Mason L Moore RA Derry S Edwards JE McQuay HJ Systematic review of topical capsaicin for the treatment of chronic pain BMJ 2004 328 991 15033881
   PubMed Web of Science ®Google Scholar
• Backonja M Wallace MS Blonsky ER NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study Lancet Neurol 2008 7 1106 1112 18977178
   PubMed Web of Science ®Google Scholar
• Baron R Mayoral V Leijon G Binder A Steigerwald I Serpell M Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy Curr Med Res Opin 2009 25 1677 1687 19480610
   PubMed Web of Science ®Google Scholar
• Jarvis B Coukell AJ Mexiletine. A review of its therapeutic use in painful diabetic neuropathy Drugs 1998 56 691 707 9806111
   PubMed Web of Science ®Google Scholar
• Harati Y Gooch C Swenson M Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy Neurology 1998 50 1842 1846 9633738
   PubMed Web of Science ®Google Scholar
• Harati Y Gooch C Swenson M Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy J Diabetes Complications 2000 14 65 70 10959067
   PubMed Web of Science ®Google Scholar
• Nelson KA Park KM Robinovitz E Tsigos C Max MB High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia Neurology 1997 48 1212 1218 9153445
   PubMed Web of Science ®Google Scholar
• Sang CN NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials J Pain Symptom Manage 2000 19 S21 S25 10687335
   PubMed Web of Science ®Google Scholar
• Watson CP Moulin D Watt-Watson J Gordon A Eisenhoffer J Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy Pain 2003 105 71 78 14499422
   PubMed Web of Science ®Google Scholar
• Gilron I Bailey JM Tu D Holden RR Weaver DF Houlden RL Morphine, gabapentin, or their combination for neuropathic pain N Engl J Med 2005 352 1324 1334 15800228
   PubMed Web of Science ®Google Scholar
• Schwartz S Etropolski M Shapiro DY Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial Curr Med Res Opin 2011 27 151 162 21162697
   PubMed Web of Science ®Google Scholar
• Vinik A Shapiro DY Karcher K Lange B Rauschkolb C Etropolski M Patient global impression of change (PGIC) and brief pain inventory-short form (BPI-SF) assessments with tapentadol extended release (ER) for painful diabetic peripheral neuropathy (DPN) 72nd American Diabetes Association 72nd Scientific Sessions June 8–12, 2012 Philadelphia, PA
   Google Scholar
• Schwartz S Etropolski MS Shapiro DY A pooled analysis evaluating efficacy and tolerability of tapentadol er for chronic, painful diabetic peripheral neuropathy (DPN) 72nd American Diabetes Association 72nd Scientific Sessions June 8–12, 2012 Philadelphia, PA
   Google Scholar
• Max M Lynch S Muir J Effects of desipramine, amitryptiline and fluoxetine on pain in diabetic neuropathy N Engl J Med 1992 326 1250 1256 1560801
   PubMed Web of Science ®Google Scholar
• Kajdasz DK Iyengar S Desaiah D Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies Clin Ther 2007 29 Suppl 2536 2546 18164920
   PubMed Web of Science ®Google Scholar
• Ziegler D Pritchett YL Wang F Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain Diabetes Care 2007 30 664 669 17327338
   PubMed Web of Science ®Google Scholar
• Goldstein DJ Lu Y Detke MJ Lee TC Iyengar S Duloxetine vs placebo in patients with painful diabetic neuropathy Pain 2005 116 109 118 15927394
   PubMed Web of Science ®Google Scholar
• Wernicke JF Pritchett YL D’Souza DN A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain Neurology 2006 67 1411 1420 17060567
   PubMed Web of Science ®Google Scholar
• Hardy T Sachson R Shen S Armbruster M Boulton AJ Does treatment with duloxetine for neuropathic pain impact glycemic control? Diabetes Care 2007 30 21 26 17192327
   PubMed Web of Science ®Google Scholar
• Sansone RA Sansone LA Pain, pain, go away: antidepressants and pain management Psychiatry (Edgmont) 2008 5 16 19 19724772
   PubMedGoogle Scholar
• Simpson DA Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy J Clin Neuromuscul Dis 2001 3 53 62 19078655
   PubMedGoogle Scholar
• Rowbotham MC Goli V Kunz NR Lei D Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study Pain 2004 110 697 706 15288411
   PubMed Web of Science ®Google Scholar
• Blom S Trigeminal neuralgia: its treatment with a new anticonvulsant drug (g-32883) Lancet 1962 21 839 840 13870089
   PubMed Web of Science ®Google Scholar
• LaRoche SM Helmers SL The new antiepileptic drugs: scientific review JAMA 2004 291 605 614 14762040
   PubMed Web of Science ®Google Scholar
• Eisenberg E Lurie Y Braker C Daoud D Ishay A Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study Neurology 2001 57 505 509 11502921
   PubMed Web of Science ®Google Scholar
• Leach MJ Marden CM Miller AA Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action Epilepsia 1986 27 490 497 3757936
   PubMed Web of Science ®Google Scholar
• Coderre TJ Melzack R The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury J Neurosci 1992 12 3665 3670 1326610
   PubMed Web of Science ®Google Scholar
• Backonja MM Use of anticonvulsants for treatment of neuropathic pain Neurology 2002 59 S14 S17 12221151
   PubMed Web of Science ®Google Scholar
• Dworkin RH Backonja M Rowbotham MC Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations Arch Neurol 2003 60 1524 1534 14623723
   PubMed Web of Science ®Google Scholar
• Backonja M Beydoun A Edwards KR Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial JAMA 1998 280 1831 1836 9846777
   PubMed Web of Science ®Google Scholar
• Landefeld CS Steinman MA The Neurontin legacy – marketing through misinformation and manipulation N Engl J Med 2009 360 103 106 19129523
   PubMed Web of Science ®Google Scholar
• DeToledo JC Toledo C DeCerce J Ramsay RE Changes in body weight with chronic, high-dose gabapentin therapy Ther Drug Monit 1997 19 394 396 9263379
   PubMed Web of Science ®Google Scholar
• Lesser H Sharma U LaMoreaux L Poole RM Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial Neurology 2004 63 2104 2110 15596757
   PubMed Web of Science ®Google Scholar
• Richter RW Portenoy R Sharma U LaMoreaux L Bockbrader H Knapp LE Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial J Pain 2005 6 253 260 15820913
   PubMed Web of Science ®Google Scholar
• Rosenstock J Tuchman M LaMoreaux L Sharma U Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial Pain 2004 110 628 638 15288403
   PubMed Web of Science ®Google Scholar
• Freynhagen R Strojek K Griesing T Whalen E Balkenohl M Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens Pain 2005 115 254 263 15911152
   PubMed Web of Science ®Google Scholar
• Freeman R Durso-Decruz E Emir B Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses Diabetes Care 2008 31 1448 1454 18356405
   PubMed Web of Science ®Google Scholar
• Tolle T Freynhagen R Versavel M Trostmann U Young JJP Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study Eur J Pain 2008 12 203 213 17631400
   PubMed Web of Science ®Google Scholar
• Arezzo JC Rosenstock J LaMoreaux L Pauer L Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial BMC Neurol 2008 8 33 18796160
   PubMed Web of Science ®Google Scholar
• Sabatowski R Galvez R Cherry DA Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial Pain 2004 109 26 35 15082123
   PubMed Web of Science ®Google Scholar
• Dworkin RH Corbin AE Young JPJr Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial Neurology 2003 60 1274 1283 12707429
   PubMed Web of Science ®Google Scholar
• van Seventer R Feister HA Young JPJr Stoker M Versavel M Rigaudy L Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial Curr Med Res Opin 2006 22 375 84 16466610
   PubMed Web of Science ®Google Scholar
• Kalso E Sodium channel blockers in neuropathic pain Curr Pharm Des 2005 11 3005 3011 16178759
   PubMed Web of Science ®Google Scholar
• Dogra S Beydoun S Mazzola J Hopwood M Wan Y Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study Eur J Pain 2005 9 543 554 16139183
   PubMed Web of Science ®Google Scholar
• Vinik AI Diabetic neuropathies: endpoints in clinical research studies LeRoith D Vinik AI Controversies in Treating Diabetes: Clinical and Research Aspects (Contemporary Endocrinology) Totowa, NJ Humana Press 2008 135 156
   Google Scholar
• Raskin P Donofrio PD Rosenthal NR Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects Neurology 2004 63 865 873 15365138
   PubMed Web of Science ®Google Scholar
• Donofrio PD Raskin P Rosenthal NR Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study Clin Ther 2005 27 1420 1431 16291415
   PubMed Web of Science ®Google Scholar
• Boyd A Barlow P Pittenger G Simmons K Vinik A Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus Diabetes Metab Syndr Obes 2010 2010 431 437 21437113
   PubMedGoogle Scholar
• Boyd A Casellini C Vinik E Vinik A Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate J Diabetes Sci Technol 2011 5 714 722 21722587
   PubMedGoogle Scholar
• Quilici S Chancellor J Lothgren M Meta-analysis of duloxetine vs pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain BMC Neurol 2009 9 6 19 19208243
   PubMed Web of Science ®Google Scholar
• Burke JP Sanchez RJ Joshi AV Cappelleri JC Kulakodlu M Halpern R Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine Pain Pract 2012 12 209 218 21676163
   PubMed Web of Science ®Google Scholar
• de Salas-Cansado M Perez C Saldana MT An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings Prim Care Diabetes Epub May 15, 2012
   Web of Science ®Google Scholar
• Bellows BK Dahal A Jiao T Biskupiak J A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy J Pain Palliat Care Pharmacother 2012 26 153 164 22509775
   PubMedGoogle Scholar
• Gilron I Bailey JM Tu D Holden RR Jackson AC Houlden RL Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial Lancet 2009 374 1252 1261 19796802
   PubMed Web of Science ®Google Scholar
• Rief W Lessons to be learned from placebo groups in clinical trials Pain 2011 152 1693 1694 21435789
   PubMed Web of Science ®Google Scholar
• Tesfaye S Tandan R Bastyr EJ3rd Kles KA Skljarevski V Price KL Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials Diabetes Care 2007 30 2626 2632 17623822
   PubMed Web of Science ®Google Scholar
• Häuser W Bartram-Wunn E Bartram C Reinecke H Tolle T Systematic review: placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors Pain 2011 152 1709 1717 21429668
   PubMed Web of Science ®Google Scholar
• Obrosova I Shevalye H Metanx alleviates diabetes-induced large and small fiber neuropathies and promotes small sensory nerve fiber regeneration Diabetes 2011 60 652-P 21270275
   PubMed Web of Science ®Google Scholar
• Fonseca VA Lavery LA Thethi TK A 24-week, double-blind, placebo controlled, multicenter study of Metanx in patients with diabetic peripheral neuropathy Program and abstracts of the American Association of Clinical Endocrinologists 2011 Annual Meeting April 13–17, 2011 San Diego, CA Abstract 212
   Google Scholar
• Piovesan EJ Teive HG Kowacs PA la Coletta MV Werneck LC Silberstein SD An open study of botulinum-A toxin treatment of trigeminal neuralgia Neurology 2005 65 1306 1308 16247065
   PubMed Web of Science ®Google Scholar
• Tsai CP Liu CY Lin KP Wang KC Efficacy of botulinum toxin type a in the relief of carpal tunnel syndrome: a preliminary experience Clin Drug Investig 2006 26 511 515
   PubMed Web of Science ®Google Scholar
• Pittler MH Ernst E Complementary therapies for neuropathic and neuralgic pain: systematic review Clin J Pain 2008 24 731 733 18806539
   PubMed Web of Science ®Google Scholar
• Tesfaye S Painful diabetic neuropathy. Aetiology and nonpharmacological treatment Veves A Clinical Management of Diabetic Neuropathy Totowa, NJ Humana Press 1998 369 386
   Google Scholar
• Abuaisha BB Costanzi JB Boulton AJ Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study Diabetes Res Clin Pract 1998 39 115 121 9597381
   PubMed Web of Science ®Google Scholar
• Kumar D Diabetic peripheral neuropathy: effectiveness of electrotherapy and amitriptyline for symptomatic relief Diabetes Care 1998 21 1322 1325 9702441
   PubMed Web of Science ®Google Scholar
• Johnson MI Bjordal JM Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain Expert Rev Neurother 2011 11 735 753 21539490
   PubMed Web of Science ®Google Scholar
• Claydon LS Chesterton LS Barlas P Sim J Dose-specific effects of transcutaneous electrical nerve stimulation (TENS) on experimental pain: a systematic review Clin J Pain 2011 27 635 647 21562411
   PubMed Web of Science ®Google Scholar
• Moran F Leonard T Hawthorne S Hypoalgesia in response to transcutaneous electrical nerve stimulation (TENS) depends on stimulation intensity J Pain 2011 12 929 935 21481649
   PubMed Web of Science ®Google Scholar
• Pantaleao MA Laurino MF Gallego NL Adjusting pulse amplitude during transcutaneous electrical nerve stimulation (TENS) application produces greater hypoalgesia J Pain 2011 12 581 590 21277840
   PubMed Web of Science ®Google Scholar
• Tesfaye S Watt J Benbow SJ Pang KA Miles J MacFarlane IA Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy Lancet 1996 348 1698 1701 8973433
   PubMed Web of Science ®Google Scholar
• Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Chaudhry V Stevens JC Kincaid J So YT Practice Advisory: utility of surgical decompression for treatment of diabetic neuropathy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 2006 66 1805 1808 16801641
   PubMed Web of Science ®Google Scholar
• Chaudhry V Russell J Belzberg A Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy Cochrane Database Syst Rev 2008 16s CD006152 18646138
   PubMedGoogle Scholar
• Endotext.org [homepage on the internet] Darmouth: Chapter 31 – Diabetic Neuropathies 2012 version [updated September 26, 2012]. Available from: http://www.endotext.org/diabetes/diabetes31/diabe-tesframe31.htm Accessed December 12, 2012
   Google Scholar